According to the survey, Romania should allot RON94.3 million to introduce 140 new drugs in compensated medicine lists. The measure would increase the Health Ministry’s costs with compensated medicines by only 1.5%.
Millions of Romanian patients would enjoy more efficient treatments, with fewer side effects, if these lists were updated to include new medicines waiting for compensation approval for more than five years, said Dan Zaharescu, executive manager of the Romanian Association of International Drug Producers (ARPIM).
Most of these drugs are used in the treatment of cancer, diabetes, heart diseases, HIV/AIDS, post-transplant and rare diseases. (EUR1=RON4.5442)